Advertisement
UK markets closed

  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     

  • FTSE 250

    20,749.90
    -72.94 (-0.35%)
     

  • AIM

    794.02
    +1.52 (+0.19%)
     

  • GBP/EUR

    1.1678
    +0.0023 (+0.20%)
     

  • GBP/USD

    1.2706
    +0.0035 (+0.28%)
     

  • Bitcoin GBP

    52,537.48
    -151.12 (-0.29%)
     

  • CMC Crypto 200

    1,365.81
    -8.03 (-0.58%)
     

  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     

  • DOW

    40,003.59
    +134.21 (+0.34%)
     

  • CRUDE OIL

    80.00
    +0.77 (+0.97%)
     

  • GOLD FUTURES

    2,419.80
    +34.30 (+1.44%)
     

  • NIKKEI 225

    38,787.38
    -132.88 (-0.34%)
     

  • HANG SENG

    19,553.61
    +177.08 (+0.91%)
     

  • DAX

    18,704.42
    -34.39 (-0.18%)
     

  • CAC 40

    8,167.50
    -20.99 (-0.26%)
     

Germany's Stada has spun off Russian business - newspaper

Reuters
·1-min read
FILE PHOTO: The logo of Stada Arzneimittel AG is pictured at their headquarters in Bad Vilbel near Frankfurt

BERLIN (Reuters) - Generic drugmaker Stada has spun off its Russian business into a separate company called Nizhpharm, the Welt am Sonntag newspaper reported on Saturday, citing a spokesperson from the German company.

Nizhpharm will operate independently and autonomously, the newspaper cited a spokesperson as saying.

Stada declined to comment on the report.

The private equity owners of Stada, which sells consumer healthcare products such as painkillers and sunscreen lotions, as well as biosimilar and generic drugs, are considering selling the company or listing it on the stock exchange, according to sources familiar with the matter.

(Reporting by Rachel More and Emma-Victoria Farr, Editing by Linda Pasquini)